Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Comparison of liver-directed combined radiotherapy versus sorafenib in patients with locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: An Asian Liver Radiotherapy Group Study.
Authors
Jinsil Seong
Department of Radiation Oncology, Yonsei Cancer Center, Seoul, South Korea;
Jinsil Seong , Jina Kim , Jason Chia-Hsien Cheng , Taek-Keun Nam , Jin Hee Kim , Wen-Yen Huang , Hiroshi Aikata , Myungsoo Kim , Jinbo Yue , Victor Ho-Fun Lee , Zhaochong Zeng
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 565)
DOI
10.1200/JCO.2023.41.4_suppl.565
Abstract #
565
Poster Bd #
D17
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Phase II study of pembrolizumab in advanced, unresectable hepatocellular carcinoma.
First Author: Lynn G. Feun
Poster
2018 Gastrointestinal Cancers Symposium
Lymphopenia and outcomes of patients with unresectable hepatocellular carcinoma treated with radiotherapy.
First Author: Sweet Ping Ng
Poster
2018 Gastrointestinal Cancers Symposium
Stereotactic-body radiotherapy for portal vein tumor thrombosis in hepatocellular carcinoma patients.
First Author: Bae Kwon Jeong
Poster
2015 Gastrointestinal Cancers Symposium
A phase III clinical trial of intra-arterial yttrium-90 glass microspheres in the treatment of patients with unresectable hepatocellular carcinoma.
First Author: Maria Angela Karpf